Investing.com -- Adaptimmune Therapeutics plc (NASDAQ: ADAP) stock plummeted 51% in pre-market trading after the company announced it would sell its cell therapy assets to US WorldMeds for $55 million ...

A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for ...

A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will need to show more robust growth in the months ahead to bolster market ...

Investment firm TD Cowen believes Apple has until the end of 2026 to make Apple Intelligence compelling, and in the meantime ...

Stryker Corporation (NYSE: SYK) is one of the top low volatility healthcare stocks to buy now. In a report released on July ...

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to invest in now. In a report released on July 14, ...

A working robotaxi is one thing; finding customers is another. Operators like Waymo and WeRide have thus far tended toward ...

VantageScore could potentially help younger borrowers or others with limited credit histories qualify for home loans or get ...

LVMH – sees its largest fashion and leather goods segment down 8% in 1H2025, it is warning of a wider industry downturn.

To be considered for admission to the S&P 500, a company must meet the following criteria: ...

CSX experienced a tough second quarter and first half of 2025, compared to the prior-year’s periods, but saw some sequential ...

After finally getting approval from the Federal Communications Commission, Skydance Media is just weeks away from completing ...